| Nuvalent, Inc. | 17.2M | US$2.13B | 22.2% |
| Revolution Medicines, Inc. | 2.39M | US$448M | 4.7% |
| Praxis Precision Medicines, Inc. | 963K | US$323M | 3.4% |
| Viatris Inc. | 20.2M | US$321M | 3.3% |
| Centene Corporation | 4.9M | US$315M | 3.3% |
| United Therapeutics Corporation | 457K | US$248M | 2.6% |
| Cogent Biosciences, Inc. | 5.01M | US$194M | 2.0% |
| Genmab A/s | 6.87M | US$189M | 2.0% |
| Brookdale Senior Living Inc. | 11.6M | US$187M | 2.0% |
| Vera Therapeutics, Inc. | 3.92M | US$168M | 1.8% |
| Ionis Pharmaceuticals, Inc. | 1.98M | US$157M | 1.6% |
| Celcuity Inc. | 1.45M | US$152M | 1.6% |
| Biocryst Pharmaceuticals, Inc. | 15.1M | US$151M | 1.6% |
| Acadia Healthcare Company, Inc. | 4.52M | US$133M | 1.4% |
| Tango Therapeutics, Inc. | 4.19M | US$131M | 1.4% |
| Adapthealth Corp. | 11.5M | US$120M | 1.2% |
| Arrowhead Pharmaceuticals, Inc. | 1.39M | US$113M | 1.2% |
| Dianthus Therapeutics, Inc. | 1.13M | US$110M | 1.1% |
| Larimar Therapeutics, Inc. | 35.6M | US$109M | 1.1% |
| Mineralys Therapeutics, Inc. | 3.96M | US$107M | 1.1% |
| Ideaya Biosciences, Inc. | 2.71M | US$101M | 1.1% |
| Xenon Pharmaceuticals Inc. | 1.62M | US$97.5M | 1.0% |
| Savara, Inc. | 13.6M | US$83.6M | 0.87% |
| Lantheus Holdings, Inc. | 753K | US$83.5M | 0.87% |
| Syndax Pharmaceuticals, Inc. | 3.78M | US$82.6M | 0.86% |
| Biomarin Pharmaceutical Inc. | 1.33M | US$76.3M | 0.80% |
| Pfizer, Inc. | 3.04M | US$73.2M | 0.76% |
| Indivior Pharmaceuticals, Inc. | 1.65M | US$67.7M | 0.71% |
| Bio-rad Laboratories, Inc. | 226K | US$66.4M | 0.69% |
| Ars Pharmaceuticals, Inc. | 7.5M | US$60.1M | 0.63% |
| Stoke Therapeutics, Inc. | 1.82M | US$59.7M | 0.62% |
| Envista Holdings Corporation | 2.21M | US$58.2M | 0.61% |
| Inspire Medical Systems, Inc. | 1.3M | US$57.9M | 0.60% |
| Caredx, Inc. | 2M | US$56.9M | 0.59% |
| Boston Scientific Corporation | 1.31M | US$56.1M | 0.59% |
| Parabilis Medicines, Inc. | 1.88M | US$51.5M | 0.54% |
| Certara, Inc. | 7.51M | US$49.2M | 0.51% |
| Disc Medicine, Inc. | 657K | US$48.1M | 0.50% |
| Bridgebio Oncology Therapeutics, Inc. | 4.89M | US$37.2M | 0.39% |
| Tyra Biosciences, Inc. | 1.02M | US$32.5M | 0.34% |
| Monopar Therapeutics Inc. | 324K | US$30M | 0.31% |
| Sionna Therapeutics, Inc. | 681K | US$30M | 0.31% |
| Avalyn Pharma Inc. | 731K | US$24.1M | 0.25% |
| Foghorn Therapeutics Inc. | 4.39M | US$21.4M | 0.22% |
| Beta Bionics, Inc. | 1.32M | US$20.7M | 0.22% |
| Alnylam Pharmaceuticals, Inc. | 67,935 | US$20.5M | 0.21% |
| Bright Minds Biosciences Inc. | 283K | US$19.9M | 0.21% |
| Odyssey Therapeutics, Inc. | 1.05M | US$19.6M | 0.20% |
| The Oncology Institute, Inc. | 3.36M | US$18.2M | 0.19% |
| Kyverna Therapeutics, Inc. | 2M | US$17.8M | 0.19% |
| Alamar Biosciences, Inc. | 600K | US$16.3M | 0.17% |
| Chemed Corp | 30,000 | US$14M | 0.15% |
| Spyglass Pharma, Inc. | 550K | US$12.2M | 0.13% |
| Hemab Therapeutics Holdings, Inc. | 275K | US$10.1M | 0.11% |
| Mobia Medical, Inc. | 671K | US$8.99M | 0.09% |
| Embecta Corp. | 2.53M | US$8.26M | 0.09% |
| Veracyte, Inc. | 101K | US$5.93M | 0.06% |
| Annexon, Inc. | 584K | US$3.33M | 0.03% |
| Alector, Inc. | 1.06M | US$2.12M | 0.02% |
| Edwards Lifesciences Corporation | 13,702 | US$1.24M | 0.01% |
| Mirum Pharmaceuticals, Inc. | 6,027 | US$706K | <0.01% |
| Humana Inc. | 917 | US$364K | <0.01% |
| Pmv Pharmaceuticals, Inc. | 8,790 | US$11,779 | <0.01% |
| Cullinan Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Enhabit, Inc. | 0 | US$0 | 0.00% |
| Kymera Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Myriad Genetics, Inc. | 0 | US$0 | 0.00% |
| Neurocrine Biosciences, Inc. | 0 | US$0 | 0.00% |
| Taysha Gene Therapies, Inc. | 0 | US$0 | 0.00% |
| Veradermics, Incorporated | 0 | US$0 | 0.00% |
| Biomx Inc. | 0 | US$0 | 0.00% |
| Catalyst Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Compass Therapeutics, Inc. | 0 | US$0 | 0.00% |